The level of carbohydrate-deficient transferrin is highly increased in bodybuilders;A szénhidrátszegény transzferrinszint testépítoknél megemelkedik

Orvosi Hetilap

Volumn 149, Issue 44, 2008, Pages 2087-2090

  Szabó, György ^a,e   Keller, Éva ^b   Szabó, Gergely ^d   Lengyel, Gabriella ^c   Fehér, János ^c  

^a Háziorvosi Szolgálat   (Hungary)

^b Somogy Megyei Kaposi Mor Oktato Korhaz Gasztroenterologiai Osztaly   (Hungary)

^c SEMMELWEIS UNIVERSITY   (Hungary)

^d UNIVERSITY OF PÉCS   (Hungary)

^e NONE   (Hungary)

Author keywords

Bodybuilder drugs; Carbohydrate deficient transferrin; CDT; Chemicals

Indexed keywords

CARBOHYDRATE DEFICIENT TRANSFERRIN;

ALCOHOL ABSTINENCE; ARTICLE; BODY BUILDING; DIET SUPPLEMENTATION; FOOD ANALYSIS; FOOD COMPOSITION; HUMAN; INJURY; LABORATORY TEST; OUTCOME ASSESSMENT; PROTEIN DETERMINATION; PROTEIN INTAKE; REFERENCE VALUE;

EID: 56749170574     PISSN: 00306002     EISSN: 17886120     Source Type: Journal    
DOI: 10.1556/OH.2008.28487     Document Type: Article

References (25)

1. Stibler H., Allgulander, C., Borg, K. G. és mtsai: Abnormal micro-heterogeneity of transferrin in serum and cerebrospinal fluid in alcoholism. Acta Med. Scand., 1978, 204, 49-56.
2. Arndt, T.: Carbohydrate deficient transferrin as a marker of chronic alcohol abuse: a critical review of preanalysis, analysis, and interpretation. Clin. Chem., 2001, 47, 13-27.
3. Chrostek, L., Cylwik, B., Szmikowski, M. és mtsa: The diagnostic accuracy of carbohydrate deficient transferrin, sialic acid and commonly used markers of alcohol abuse during abstinence. Clin. Chim. Acta, 2006, 364, 167-171.
4. Golka, K., Sondermann, R., Reich, S. E. és mtsa: Carbohydrate-deficient transferrin (CDT) as a biomarker in persons suspected of alcohol abuse. Toxicol. Lett., 2004, 151, 235-241.
5. Fehér J., Lengyel G., Szabó Gy.: A széhidrátszegény transzferrin mint az alkoholfogyasztás jelzoje. Orv. Hetil., 2006, 147, 1915-1920.
6. Schaper M., Demes, P., Kiesswetter, E. és mtsai: Colour vision and occupational toluene exposure: results of repeated examinations. Toxicol. Lett., 2004, 151, 193-202.
7. Arndt, T, Keller, T.: Forensic analysis of carbohydrate-deficient transferrin (CDT): implementation of a screening and confirmatory analysis concept is hampered by the lack of CDT isoform standards. Forensic Sci. Int., 2004, 146, 9-16.
8. Bilban, M., Vrhovec, S., Karlovsek, M. Z.: Blood biomarkers of alcohol abuse. Arh. Hig. Rada. Toksikol., 2003, 54, 253-259.
9. Pérez-Cérdá, C., Quelhas, D., Vega, A. I. és mtsai: Screening using serum percentage of carbohydrate-deficient transferrin for congenital disorders of glycosylation in children with suspected metabolic disease. Clin. Chem., 2008, 54, 93-100.
10. Anton, R. F., Youngblood, M.: Factors affecting %CDT status at entry into a multisite clinical treatment trial: experience from the COMBINE Study. Alcohol. Clin. Exp. Res., 2006, 11, 1879-1883.
11. Biffi, S., Tamaro, G., Bortot, B. és mtsai: Carbohydrate-deficient transferrin (CDT) as a biochemical tool for the screening of congenital disorders of glycosylation (CDGs). Clin. Biochem., 2007, 40, 1431-1434.
12. Bergström, J. P., Helander, A.: Influence of alcohol use, ethnicity, age, gender, BMI and smoking on the serum transferrin glycoform pattern: Implications for use of carbohydrate-deficient transferrin (CDT) as alcohol biomarker. Clin. Chim. Acta, 2008, 388, 59-67.
13. Szabó Gy., Keller É, Környei L. és mtsai: Szénhidrátszcgény transzferrinvizsgálat eredményei munkahelyi vegyszer-expozíció után. Orv. Hetil., 2008, 149, 415-419.
14. Stibler, H., Borg, S., Joustra, M.: Micro anion exchange chromatography of carbohydrate deficient transferrin in serum in relation to alcohol consumption (Swedish Patent 8400587-5). Alcohol. Clin. Exp. Res., 1986, 10, 535-544.
15. Myrick, H, Henderson, S., Anton, R. F.: Utility of a new assay for carbohydrate-deficient transferrin (BIORAD %CDT TIA) to monitor abstinence during treatment outcome study. Alcohol. Clin. Exp. Res., 2001, 25, 1330-1334.
16. Szabó Gy., Környei L., Keller É. és mtsai: A szénhidrátszegény transzferrin szintje a magyarországi népességben a nem és kor viszonylatdban. Orv. Hetil., 2007, 148, 1409-1413.
17. Jakab L.: A szénhidrátszegény transzferrin kórtani vonatkozásai. Orv. Hetil., 2007, 148, 2202.
18. Cylwik, B., Chrostek, L., Jakimiuk, B. és mtsai: Serum level of sialic acid (SA) and carbohydrate deficient transferrin (CDT) in type 2 diabetes mellitus with microvascular complications. J. Clin. Lab. Anal., 2006, 20, 68-73.
19. Figlie, N. B., Benedito-Silva, A. A., Monteiro, M. G. és mtsa: Biological Markers of alcohol consumption in nondrinkers, drinkers and alcohol dependent Brazilian patients". Alcohol. Clin. Exp. Res., 2002, 26, 1062-1069.
20. Fleming, M, Mundt, M.: Carbohydrate deficient transferrin: Validity of new alcohol biomarker in a sample of patients with diabetes and hypertension. J. Am. Board Fa. Pract., 2004, 17, 247-255.
21. Ohtsuka, T., Tsutsumi, N., Fukumura, A. és mtsai: Use of serum carbohydrate-deficient transferrin values to exclude alcoholic hepatitis from non-alcoholic steatohepatitis: a pilot study. Alcohol. Clin. Exp. Res., 2005, 29 (12 Suppl.) 236-239.
22. Steiskal, D., Ruzicka, V., Fanfrdlova, G. és mtsai: High adiponectin and TNF-alfa levels in moderate drinkers suffering from liver steatosis: comparison with non-drinkers suffering from similar hepatopathy. Biomed. Papers, 2005, 149, 93-99.
23. Chrostek, L., Cylwik, B., Poplawska, A. és mtsai: Serum sialic acid and carbohydrate-deficient transferrin concentration in type 2 diabetes mellitus with andwithout macrovascular complications. Diabet. Nutr. Metab., 2004, 17, 371-373.
24. Whitfield, J. B., Fletcher, L. M., Murphy, T. M. és mtsai: Smoking, obesity, and hypertension alter the dose-response curve and test sensitivity of carbohydrate-deficient transferrin as a marker of alcohol intake. Clin. Chem., 1998, 44, 2480-2489.
25. Kaukiainen, A., Vehmas, T., Rantala, K. és mtsai: Results of common laboratory tests in solvent-exposed workers. Internat. Arch. Occup. Environ. Health, 2004, 77, 39-46.